Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of PUS1 knockdown on gene expression in MDA-MB-231 breast cancer cells

ABSTRACT: Effect of PUS1 knockdown on gene expression in MDA-MB-231 breast cancer cells

PROVIDER: PRJNA873771 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21203786_1.fastq.gz	Fastqsanger.gz
	SRR21203786_2.fastq.gz	Fastqsanger.gz
	SRR21203787_1.fastq.gz	Fastqsanger.gz
	SRR21203787_2.fastq.gz	Fastqsanger.gz
	SRR21203788_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Effect of PUS1 knockdown on gene expression in MDA-MB-231 breast cancer cells

Project description:To identify the downstream target genes of PUS1 on breast cancer cells, we established MDA-MB-231 cell lines in which PUS1 has been knocked down by shRNA. We then performed gene expression profiling analysis using data obtained from RNA-seq of PUS1 knockdownMDA-MB-231 cells as well as negative control shRNA group

2022-08-29 | GSE212074 | GEO

The miRNA profiling in MDA-MB-231, MDA-MB-231/E1A and knockdown of Dicer in MDA-MB-231/E1A cells

Project description:Dicer, RNase III endonuclease, is an essential enzyme in miRNA biogenesis that regulates target gene expression, and it has been reported that aberrant expressions of Dicer associate with the clinical outcomes of patients in various cancers. To explore the miRNA differencial expression regulated by Dicer in MDA-MB-231/E1A cells, the microarray profiling analysis was employed to conduct differentially expressed miRNAs in stable MDA-MB-231/vector, MDA-MB-231/E1A, and MDA-MB-231/E1A/shDicer cells. The four groups including vector control, E1A-expressing and Dicer knockdown in E1A-expressing MDA-MB-231 cells were harvested and RNA were isolated. Two independent experiments were performed for each group.

2016-01-16 | E-GEOD-76924 | biostudies-arrayexpress

UGDH knockdown in MDA-MB-231

Project description:UGDH knockdown in MDA-MB-231

| PRJNA486780 | ENA

LC-MSMS MDA-MB-231 with knockdown of ELOVL5 and IGFBP6 genes

Project description:Identification of changes in protein expression by label-free shotgun proteomics in breast cancer MDA-MB-231 cells with knockdown of ELOVL5 and IGFBP6 genes in comparison with control MDA-MB-231 cells.

2021-05-20 | PXD023892 | Pride

Secretome of control and srGAP1 knockdown MDA-MB-231 cells

Project description:Proteomic of the secretome of control or srGAP knockdown MDA-MB-231 cells

2022-07-11 | PXD026102 | Pride

The miRNA profiling in MDA-MB-231, MDA-MB-231/E1A and knockdown of Dicer in MDA-MB-231/E1A cells

2016-01-16 | GSE76924 | GEO

Expression data from CD44-knockdown MDA-MB-231 human breast cancer cells.

Project description:CD44, an adhesion molecule that binds to extracellular matrix, primarily to hyaluronan (HA), has been implicated in cancer cell migration, invasion, and metastasis. CD44 has also recently been recognized as a marker for stem cells of several types of cancer. However, the roles of CD44 in the development of bone metastasis still remain unclear. To explore this issue, we established the MDA-MB-231 human breast cancer cells stably expressing short hairpin RNA against CD44. The CD44-knockdown MDA-MB-231 cells (MDA-MB-231 shCD44-2 and shCD44-3) were analyzed. As control, MDA-MB-231 cells stably expressing shRNA against firefly luciferase (shLuc) were used. Total of three samples. No replicates.

2013-04-24 | E-GEOD-45613 | biostudies-arrayexpress

FOXC2 knockdown in MDA-MB-231 cells

Project description:FOXC2 knockdown in MDA-MB-231 cells

| PRJNA971226 | ENA

Phosphoproteomics for MDA-MB-231 cell lines when knockdown of DUSP14

Project description:Phosphoproteomics for MDA-MB-231 cell lines when knockdown of DUSP14

| PXD065884 |

FOXC2 knockdown in MDA-MB-231 cells

Project description:To determine gene expression changes in vasculogenic mimicry competent human breast cancer cells with loss of FOXC2 we performed RNA-seq of MDA-MB-231 cells with FOXC2 knockdown.

2023-07-26 | GSE232212 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data